BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a company name.

Osi Pharmaceuticals

BioCentury | Oct 21, 2024
Product Development

EGFR: A best-in-class strategy study

The target is one of industry’s most notable case studies in continued product differentiation and market growth 
BioCentury | Jun 28, 2022
Emerging Company Profile

Sling: advancing an oral alternative to Tepezza for thyroid eye

First company created by sole investor TPG cleared for Phase IIb trial of asset Astellas had studied in cancer
BioCentury | Sep 11, 2021
Finance

Fred Frank, co-founder of the biotech industry, is dead at 89

His influence can be found on deals that built biopharma ecosystem
BioCentury | Dec 11, 2018
Emerging Company Profile

Black Diamond: Mapping allostery

Black Diamond debuts with plans to identify, target allosteric mutant oncogenes
BioCentury | Jun 24, 2016
Company News

Management tracks

BioCentury | Sep 22, 2014
Company News

Ophthotech, Novartis deal

BioCentury | Aug 18, 2014
Clinical News

Fovista: Phase IIa started

BioCentury | Aug 4, 2014
Product Development

Beyond biopsy

Why AZ chose two partners for non-invasive companion diagnostics for NSCLC
Items per page:
1 - 10 of 792